Ara-C

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Auto Stem Cell Transplant for Lymphoma Patients

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

Risk-adapted Therapy for Primary Acute Myeloid Leukemia

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

Selinexor (KPT-330) in Older Patients With Relapsed AML

Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia

A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia

Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)

PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML